1. Home
  2. HROW vs DK Comparison

HROW vs DK Comparison

Compare HROW & DK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • DK
  • Stock Information
  • Founded
  • HROW 1998
  • DK 2001
  • Country
  • HROW United States
  • DK United States
  • Employees
  • HROW N/A
  • DK N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • DK Integrated oil Companies
  • Sector
  • HROW Health Care
  • DK Energy
  • Exchange
  • HROW Nasdaq
  • DK Nasdaq
  • Market Cap
  • HROW 1.1B
  • DK 1.0B
  • IPO Year
  • HROW N/A
  • DK 2006
  • Fundamental
  • Price
  • HROW $30.66
  • DK $21.79
  • Analyst Decision
  • HROW Strong Buy
  • DK Hold
  • Analyst Count
  • HROW 6
  • DK 12
  • Target Price
  • HROW $59.00
  • DK $17.48
  • AVG Volume (30 Days)
  • HROW 433.0K
  • DK 1.7M
  • Earning Date
  • HROW 08-06-2025
  • DK 08-05-2025
  • Dividend Yield
  • HROW N/A
  • DK 4.69%
  • EPS Growth
  • HROW N/A
  • DK N/A
  • EPS
  • HROW N/A
  • DK N/A
  • Revenue
  • HROW $212,858,000.00
  • DK $11,366,100,000.00
  • Revenue This Year
  • HROW $44.92
  • DK N/A
  • Revenue Next Year
  • HROW $38.12
  • DK N/A
  • P/E Ratio
  • HROW N/A
  • DK N/A
  • Revenue Growth
  • HROW 53.49
  • DK N/A
  • 52 Week Low
  • HROW $19.31
  • DK $11.03
  • 52 Week High
  • HROW $59.23
  • DK $25.68
  • Technical
  • Relative Strength Index (RSI)
  • HROW 57.58
  • DK 66.03
  • Support Level
  • HROW $30.01
  • DK $18.94
  • Resistance Level
  • HROW $31.63
  • DK $23.00
  • Average True Range (ATR)
  • HROW 1.59
  • DK 1.07
  • MACD
  • HROW 0.02
  • DK 0.10
  • Stochastic Oscillator
  • HROW 66.10
  • DK 75.10

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. Delek's logistics segment sells portions of the petroleum products its refineries produce. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

Share on Social Networks: